Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Hydrocephalus in neuromyelitis optica.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Natalizumab Continued Past 24 Months Safely in MS
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Environmental factors in multiple sclerosis.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Efficacy of lower fingolimod doses in the treatment of MS.
Neuromyelitis optica in a child with Aicardi-Goutières syndrome.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses.
Intractable vomiting and hiccups as the presenting symptom of neuromyelitis optica.
Magnetic resonance imaging in neuromyelitis optica.
The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.

Pages